O'BRIEN JR, JOHN M,DEFRANCO, EMILY A,MUSE, KENNETH N,CREASY, GEORGE,OBRIEN JR, JOHN M
申请号：
NZ57911408
公开号：
NZ579114A
申请日:
2008.02.05
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Disclosed is the use of a progesterone selected from natural progesterone, 17-alphahydroxyprogesterone caproate, medroxyprogesterone acetate, norethindrone, norethindrone acetate, norethindrone enanthate, desogestrel, levonorgestrel, lynestrenol, ethynodiol diacetate, norgestrel, norgestimate, norethynodrel, gestodene, drospirenone, trimegestone, levodesogestrel, gestodyne, nesterone and etonogestrel, in the manufacture of a medicament for treating or preventing the onset of preterm labour and subsequent preterm birth in a pregnant woman with a short cervix of from 1.0 to 3.5 cm, wherein the progesterone is used in an amount sufficient to minimize the shortening of the cervix.
